Literature DB >> 6100605

Safety and efficacy of enalapril. Summing up the evidence.

C T Dollery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6100605

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


× No keyword cloud information.
  6 in total

1.  A need for new converting enzyme inhibitors?

Authors:  S G Ball; J I Robertson
Journal:  Br Med J (Clin Res Ed)       Date:  1985-01-19

2.  Cough associated with captopril and enalapril.

Authors:  D M Coulter; I R Edwards
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-13

Review 3.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 4.  Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  P A Todd; R C Heel
Journal:  Drugs       Date:  1986-03       Impact factor: 9.546

Review 5.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

6.  A dose-response study of HOE 498, a new non-sulphydryl converting enzyme inhibitor, on blood pressure, pulse rate and the renin-angiotensin-aldosterone system in normal man.

Authors:  P J Manhem; S G Ball; J J Morton; G D Murray; B J Leckie; R Fraser; J I Robertson
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.